Teva plans 'risky' price rise on US medicines | Financial Times
Israeli drugmaker Teva to cut quarter of global work force | AP News
Teva Pharmaceuticals - Wikipedia
Teva's recall of U.S.-made drugs latest example of contamination fears in generic marketplace; report says Lilly, Pfizer and former Mylan plant in Morgantown have been cited in the past | WV News | wvnews.com
Teva Eyes 25 Percent of the $750 Million EpiPen Market by Year's End | BioSpace
Teva CEO says manufacturing cuts will keep coming even after $3B reduction achieved | FiercePharma
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs - BBC News
Troubled Teva plant in Hungary faces an FDA crackdown - STAT
Teva Pharmaceuticals Sterile Manufacturing Facility, Ulm - Pharmaceutical Technology
Drugmaker to pay $1.2 billion to settle 'pay for delay' lawsuit | PBS NewsHour
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/7333YBOGCNAO7EPBSMO24XX7BA.jpg "Teva Pharmaceuticals to narrow focus on drugs, trim costs")
Teva Pharmaceuticals to narrow focus on drugs, trim costs
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Drugmaker Teva makes $40B bid for rival Mylan
Award of Merit Manufacturing: TEVA Biologics Manufacturing Facility | 2018-10-16 | Engineering News-Record
Teva Pharmaceuticals Sterile Manufacturing Facility, Ulm - Pharmaceutical Technology
Teva's 70+ manufacturing sites could be halved in efficiency drive
Taiyo Pharmaceutical Industry, Contract Manufacturing Plant - Pharmaceutical Technology
Teva to cut 14,000 jobs | Business | Chemistry World
Teva, the world's largest generic drugmaker, is cutting 14,000 workers - Los Angeles Times
Teva halts production at sterile injectables plant to address FDA concerns | FiercePharma
Novartis, Mylan and Teva to supply tens of millions of chloroquine tablets to fight COVID-19 | FiercePharma
Teva makes first foray into medical cannabis sector, with new distribution deal | The Times of Israel
Teva Pharmaceutical CEO says health-care is facing 'huge disruption'
Teva plans the large-scale production of monoclonal antibodies in Ulm - Healthcare industry
Teva Recalls U.S.-Made Drugs Following Contamination Fears
For pharma services firms, big assets can pose major risks
